2) Abnormal T lymphocyte activation
T淋巴细胞异常活化
3) antigen-specific T cell activation
抗原特异性T细胞活化
1.
VIR576 inhibits antigen-specific T cell activation by binding to the transmembrane domain of T cell receptor
VIR576通过与TCR跨膜区结合抑制抗原特异性T细胞活化
4) T cell activation
T细胞活化
1.
The inhibitory effect of the altered collagen II peptide on T cell activation in patients with rheumatoid arthritis;
利用II型胶原变构肽抑制类风湿关节炎患者T细胞活化的研究
2.
Objective To analyze the role of 4-1BBL, expressed in the regulation of human peripheral blood T cell activation.
结论在T细胞活化过程中,活化T细胞表达的4-1BBL分子通过逆向信号抑制其细胞因子的分泌和上调负性调控分子,进而抑制T细胞的过度活化和下调T细胞介导的免疫应答。
5) activated T cell
活化T细胞
1.
Objective:To observe the effects of recombinant human granulocyte colony-stimulating factor(rhG-CSF)on peripheral active signal of T cell surface antigen(CD4+CD28+,CD8+CD28+),activated T cells,and regulatory T cells during mobilization of hematopoietic stem cells and its safety of application in health donors.
目的:观察重组人粒细胞集落刺激因子(rhG-CSF)在动员造血干细胞时对健康供者外周血T细胞表面活化信号(CD4+CD28+,CD8+CD28+)、活化T细胞(CD4+CD25low)和调节性T细胞(CD4+CD25high)的影响及其应用的安全性。
2.
To investigate expression of the novel membrane molecule p140 on activated T cell in patients after renal transplantation, im-munofluoescence staining and FCM analysis were utilized to monitor the expression of p140, and transplanted renal biopsy was employed to confirm acute allograft rejection.
结果表明,P140在肾移植患者淋巴细胞亚群及活化T细胞有弱表达,存在排斥反应时表达增强。
6) activated T cells
活化T细胞
1.
Aim To investigate the distribution, relative molecular mass(Mr)and function of a novel membrane molecule p140 expressed on activated T cells.
目的观察一种新的活化T细胞膜分子p140的分布、相对分子质量(Mr)和功能。
2.
The widely accepted pathogenetic process of EAE and MS is that activated T cells migrate to the CNS and develop inflammatory lesion, and some chemokines and their receptors preferentially expressed in T ce.
实验性自身免疫性脑脊髓炎(experimental autoimmune encephalomyelitis,EAE)是一种由活化T细胞(主要是Th1细胞)介导的器官特异性自身免疫性疾病,主要病理特征为血管周围炎性细胞浸润和神经脱髓鞘反应,在临床症状、生化指标及病理等方面与MS具有相似的特征,因此EAE被
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条